Figure 1From: Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinibPlasma pharmacodynamics of soluble protein biomarkers during treatment with sunitinib. (A) VEGF-A and VEGF-C; (B) sKIT and sVEGFRs-2 and -3. C, cycle; D, day.Back to article page